{"id":"https://openalex.org/W91745452","doi":null,"title":"Characterization of Hypertriglyceridemia in Obese Diabetic TallyHo/Jng Mice","display_name":"Characterization of Hypertriglyceridemia in Obese Diabetic TallyHo/Jng Mice","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W91745452","mag":"91745452"},"language":"en","primary_location":{"id":"mag:91745452","doi":null,"is_oa":false,"landing_page_url":"https://trace.tennessee.edu/cgi/viewcontent.cgi?article=3001&context=utk_gradthes","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078127323","display_name":"Jennifer Melanie Fortuna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75027704","display_name":"University of Tennessee at Knoxville","ror":"https://ror.org/020f3ap87","country_code":"US","type":"education","lineage":["https://openalex.org/I75027704"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jennifer Melanie Fortuna","raw_affiliation_strings":["#N##TAB##TAB##TAB##TAB# University of Tennessee#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# University of Tennessee#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I75027704"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078127323"],"corresponding_institution_ids":["https://openalex.org/I75027704"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.5404999852180481,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.5404999852180481,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.4392000138759613,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9490000009536743},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8669999837875366},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8640000224113464},{"id":"https://openalex.org/keywords/apolipoprotein-c-iii","display_name":"apolipoprotein C-III","score":0.6119999885559082},{"id":"https://openalex.org/keywords/bezafibrate","display_name":"bezafibrate","score":0.8019999861717224},{"id":"https://openalex.org/keywords/hepatic-lipid-metabolism","display_name":"hepatic lipid metabolism","score":0.4659999907016754},{"id":"https://openalex.org/keywords/hepatic-glucose-production","display_name":"hepatic glucose production","score":0.4580000042915344},{"id":"https://openalex.org/keywords/hepatic-gluconeogenesis","display_name":"hepatic gluconeogenesis","score":0.6639999747276306},{"id":"https://openalex.org/keywords/hepatic-lipogenesis","display_name":"hepatic lipogenesis","score":0.6299999952316284},{"id":"https://openalex.org/keywords/hepatic-lipolysis","display_name":"hepatic lipolysis","score":0.6230000257492065},{"id":"https://openalex.org/keywords/hepatic-insulin-signaling","display_name":"hepatic insulin signaling","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.7755593061447144},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.7697855234146118},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7440073490142822},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7239252924919128},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.7029719352722168},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6849019527435303},{"id":"https://openalex.org/C2780988686","wikidata":"https://www.wikidata.org/wiki/Q14375936","display_name":"Hyperinsulinemia","level":4,"score":0.6726083755493164},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6369154453277588},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.4805172383785248},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4531446397304535},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.44894030690193176},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3048126995563507},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.15028363466262817}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:91745452","doi":null,"is_oa":false,"landing_page_url":"https://trace.tennessee.edu/cgi/viewcontent.cgi?article=3001&context=utk_gradthes","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W220262962","https://openalex.org/W576301569","https://openalex.org/W1511319154","https://openalex.org/W1527680278","https://openalex.org/W1549915690","https://openalex.org/W1580646470","https://openalex.org/W1594959615","https://openalex.org/W1889257304","https://openalex.org/W1900613292","https://openalex.org/W1963675250","https://openalex.org/W1968375269","https://openalex.org/W1970298287","https://openalex.org/W1974292355","https://openalex.org/W1980662936","https://openalex.org/W1984578526","https://openalex.org/W2003839321","https://openalex.org/W2008404887","https://openalex.org/W2012354624","https://openalex.org/W2026015192","https://openalex.org/W2029164903","https://openalex.org/W2031053394","https://openalex.org/W2037238067","https://openalex.org/W2044210064","https://openalex.org/W2045493386","https://openalex.org/W2047589448","https://openalex.org/W2052953259","https://openalex.org/W2054121674","https://openalex.org/W2054851194","https://openalex.org/W2057271976","https://openalex.org/W2058166721","https://openalex.org/W2059842910","https://openalex.org/W2060596699","https://openalex.org/W2069139828","https://openalex.org/W2069458734","https://openalex.org/W2069560861","https://openalex.org/W2070249144","https://openalex.org/W2075345318","https://openalex.org/W2078524991","https://openalex.org/W2080995480","https://openalex.org/W2081064907","https://openalex.org/W2091764130","https://openalex.org/W2100481760","https://openalex.org/W2103738634","https://openalex.org/W2105362864","https://openalex.org/W2105498514","https://openalex.org/W2111933310","https://openalex.org/W2117219749","https://openalex.org/W2120282127","https://openalex.org/W2120876597","https://openalex.org/W2121788140","https://openalex.org/W2123289485","https://openalex.org/W2125239457","https://openalex.org/W2126858422","https://openalex.org/W2128639389","https://openalex.org/W2132554143","https://openalex.org/W2137813761","https://openalex.org/W2138445372","https://openalex.org/W2141997577","https://openalex.org/W2142371147","https://openalex.org/W2145118099","https://openalex.org/W2148822988","https://openalex.org/W2152316341","https://openalex.org/W2155725887","https://openalex.org/W2158075365","https://openalex.org/W2160942744","https://openalex.org/W2164376306","https://openalex.org/W2167706489","https://openalex.org/W2169466388","https://openalex.org/W2184335570","https://openalex.org/W2408815636","https://openalex.org/W2755633499","https://openalex.org/W3064710101"],"related_works":["https://openalex.org/W192185772","https://openalex.org/W2151447950","https://openalex.org/W3177322528","https://openalex.org/W63008016","https://openalex.org/W2078524200","https://openalex.org/W164591759","https://openalex.org/W7097899776","https://openalex.org/W2243214714","https://openalex.org/W2104652533","https://openalex.org/W4400140639"],"abstract_inverted_index":{"Over":[0],"the":[1,9,21,49,96,100,105,118,224,253,259,268,272,297,319,355,370,379,404,418,439,466,469,474,478],"past":[2],"20":[3],"years,":[4],"a":[5,76,205,325,388,446],"major":[6],"shift":[7],"in":[8,122,146,232,245,263,283,310,349,360,374,411,421,433,448,452,462,465,482],"type":[10],"2":[11],"diabetes":[12,61],"mellitus":[13],"(T2DM)":[14],"epidemic":[15],"has":[16,25,39,235],"occurred.":[17],"Even":[19],"though":[20],"etiology":[22],"of":[23,58,78,99,107,120,128,139,227,252,261,330,354,366,369,387,457],"T2DM":[24,121,135,212],"not":[26,307,431,472],"yet":[27],"been":[28],"discovered,":[29],"insulin":[30,181,217,238,278,480],"resistance,":[31,218],"associated":[32,179,242],"with":[33,60,125,137,164,180,223,243],"plasma":[34,66,273,395,400,408,422],"lipid":[35,67,274,396],"and":[36,54,86,102,150,171,183,221,266,280,381,414,455],"lipoprotein":[37,73,83,450],"abnormalities,":[38,68],"shed":[40],"light":[41],"to":[42,48,176,257,314,341,378,392,403,442,445],"this":[43,233,284],"chronic":[44],"disease.":[45],"According":[47],"Centers":[50],"for":[51,134,211,477],"Disease":[52],"Control":[53],"Prevention":[55],"(CDC),":[56],"97%":[57],"individuals":[59],"have":[62],"one":[63],"or":[64,428],"more":[65],"including":[69],"decreased":[70],"high":[71],"density":[72,82,300],"(HDL)":[74],"cholesterol,":[75],"predominance":[77],"small":[79],"dense":[80],"low":[81,299],"(LDL)":[84],"particles":[85],"hypertriglyceridemia":[87],"(HTG).":[88],"Diabetic":[90],"patients":[91],"often":[92,103,162],"develop":[93],"hyperlipidemia":[94],"at":[95,336],"early":[97,225],"stage":[98],"disease":[101],"before":[104],"onset":[106,226],"overt":[108],"hyperglycemia":[109,219],"(diabetes).":[110],"It":[112],"is":[113,161,204,240,471],"also":[114],"well":[115],"established":[116,207],"that":[117,213,237,270,296],"prevalence":[119,127],"theUnited":[123],"Statesisassociated":[124],"increased":[126,327],"obesity.":[129],"The":[131,199,250],"therapeutic":[132],"plan":[133],"begins":[136],"modifications":[138],"lifestyle,":[140],"such":[141],"as":[142],"physical":[143],"activity,":[144],"changes":[145],"diet,":[147],"weight":[148],"loss,":[149],"smoking":[151],"cessation":[152],"(2005":[153],"American":[154],"Diabetes":[155],"Association":[156],"clinical":[157],"guidelines).":[158],"This":[160],"concomitant":[163],"pharmacological":[165],"therapy.":[166],"Statins,":[168],"fibrates,":[169],"niacin,":[170],"thiazolidinediones":[172],"are":[173],"commonly":[174],"used":[175],"treat":[177],"dyslipidemia":[178,222],"resistance":[182,239,279],"T2DM.":[184],"TALLYHO/Jng":[200],"(TH)":[201],"mouse":[202],"strain":[203],"newly":[206],"polygenic":[208],"inbred":[209],"model":[210],"shows":[214],"obesity,":[215],"hyperinsulinemia,":[216],"(males),":[220],"HTG.":[228],"Previous":[230],"work":[231],"laboratory":[234],"revealed":[236],"profoundly":[241],"HTG":[244,262,440,470],"TH":[246,264,311,322,350,361,375,415,434,453,483],"male":[247],"mice.":[248,317,351,384,416,435,484],"aim":[251],"present":[254],"study":[255],"was":[256,306,430],"characterize":[258],"pathogenesis":[260],"mice":[265,312,323,376],"test":[267],"hypothesis":[269],"lowering":[271],"levels":[275,397],"will":[276],"improve":[277],"glucose":[281,401,426],"metabolism":[282],"model.":[285],"In":[292,352,437],"vivo":[293],"studies":[294],"indicated":[295],"very":[298],"lipoprotein-triglyceride":[301],"(VLDL-TG)":[302],"production":[303],"from":[304],"liver":[305],"significantly":[308,326,406],"altered":[309],"compared":[313,340,377],"control":[315],"B6":[316,342,383,413],"On":[318],"other":[320],"hand,":[321],"showed":[324],"residual":[328],"percentage":[329],"injected":[331],"[3H]":[332],"TG-":[333],"labeled":[334],"VLDL":[335],"all":[337],"sampling":[338],"times":[339],"mice,":[343,362,454],"indicating":[344],"slower":[345],"VLDL-TG":[346,357],"clearance":[347,358,451],"rate":[348,359],"support":[353],"slowed":[356],"we":[363],"found":[364],"evidence":[365],"hepatic":[367],"over-expression":[368],"Apo":[371,458],"C-III":[372,459],"gene":[373],"age-":[380],"sex-matched":[382],"Finally,":[385],"addition":[386],"drug":[389],"bezafibrate,":[390],"known":[391],"selectively":[393],"lower":[394],"without":[398],"changing":[399],"levels,":[402,424],"diet":[405],"reduced":[407],"TG":[409,423],"concentrations":[410],"both":[412],"Despite":[417],"remarkable":[419],"decrease":[420],"either":[425],"tolerance":[427],"uptake":[429],"improved":[432],"summary,":[438],"appears":[441],"be":[443,461],"due":[444],"defect":[447,476],"triglyceride-rich":[449],"overproduction":[456],"may":[460],"part":[463],"involved":[464],"pathogenesis.":[467],"Further,":[468],"likely":[473],"primary":[475],"impaired":[479],"action":[481],"These\u2026":[485]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}